News for Healthier Living

Lipid droplet gene signatures classify liver cancer and identify PLIN3 as a therapeutic target

Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer and remains one of the leading causes of cancer-related deaths worldwide. Despite advances in targeted therapies and immunotherapy, substantial molecular heterogeneity continues to limit accurate prognostic prediction and effective treatment selection. While metabolic reprogramming is increasingly recognized as a hallmark of HCC, the contribution of lipid droplet-associated genes (LDAGs) to tumor classification and disease progression has remained poorly defined.

August 18, 2026


August 18 2026

August 17 2026

August 16 2026

August 15 2026

August 14 2026

August 13 2026

August 12 2026

August 11 2026

August 10 2026

August 7 2026

August 6 2026

August 5 2026

August 4 2026